Form 8-K - Current report:
SEC Accession No. 0001193125-25-114430
Filing Date
2025-05-07
Accepted
2025-05-07 07:05:18
Documents
51
Period of Report
2025-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d915177d8k.htm   iXBRL 8-K 27232
2 EX-99.1 d915177dex991.htm EX-99.1 83459
3 EX-99.2 d915177dex992.htm EX-99.2 48399
7 GRAPHIC g915177ex99_2s10g1.jpg GRAPHIC 128146
8 GRAPHIC g915177ex99_2s11g1.jpg GRAPHIC 117322
9 GRAPHIC g915177ex99_2s12g1.jpg GRAPHIC 82333
10 GRAPHIC g915177ex99_2s13g1.jpg GRAPHIC 111966
11 GRAPHIC g915177ex99_2s14g1.jpg GRAPHIC 119863
12 GRAPHIC g915177ex99_2s15g1.jpg GRAPHIC 69695
13 GRAPHIC g915177ex99_2s16g1.jpg GRAPHIC 116509
14 GRAPHIC g915177ex99_2s17g1.jpg GRAPHIC 77672
15 GRAPHIC g915177ex99_2s18g1.jpg GRAPHIC 80842
16 GRAPHIC g915177ex99_2s19g1.jpg GRAPHIC 72925
17 GRAPHIC g915177ex99_2s1g1.jpg GRAPHIC 50798
18 GRAPHIC g915177ex99_2s20g1.jpg GRAPHIC 79626
19 GRAPHIC g915177ex99_2s21g1.jpg GRAPHIC 101167
20 GRAPHIC g915177ex99_2s22g1.jpg GRAPHIC 112602
21 GRAPHIC g915177ex99_2s23g1.jpg GRAPHIC 129332
22 GRAPHIC g915177ex99_2s24g1.jpg GRAPHIC 95540
23 GRAPHIC g915177ex99_2s25g1.jpg GRAPHIC 106207
24 GRAPHIC g915177ex99_2s26g1.jpg GRAPHIC 116842
25 GRAPHIC g915177ex99_2s27g1.jpg GRAPHIC 116760
26 GRAPHIC g915177ex99_2s28g1.jpg GRAPHIC 78803
27 GRAPHIC g915177ex99_2s29g1.jpg GRAPHIC 103685
28 GRAPHIC g915177ex99_2s2g1.jpg GRAPHIC 174927
29 GRAPHIC g915177ex99_2s30g1.jpg GRAPHIC 90356
30 GRAPHIC g915177ex99_2s31g1.jpg GRAPHIC 105537
31 GRAPHIC g915177ex99_2s32g1.jpg GRAPHIC 98125
32 GRAPHIC g915177ex99_2s33g1.jpg GRAPHIC 90453
33 GRAPHIC g915177ex99_2s34g1.jpg GRAPHIC 107658
34 GRAPHIC g915177ex99_2s35g1.jpg GRAPHIC 140474
35 GRAPHIC g915177ex99_2s3g1.jpg GRAPHIC 155206
36 GRAPHIC g915177ex99_2s4g1.jpg GRAPHIC 104959
37 GRAPHIC g915177ex99_2s5g1.jpg GRAPHIC 127702
38 GRAPHIC g915177ex99_2s6g1.jpg GRAPHIC 74405
39 GRAPHIC g915177ex99_2s7g1.jpg GRAPHIC 90894
40 GRAPHIC g915177ex99_2s8g1.jpg GRAPHIC 80636
41 GRAPHIC g915177ex99_2s9g1.jpg GRAPHIC 94743
42 GRAPHIC g915177g0507021902101.jpg GRAPHIC 2666
  Complete submission text file 0001193125-25-114430.txt   5283053

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20250507.xsd EX-101.SCH 2867
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20250507_lab.xml EX-101.LAB 17234
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20250507_pre.xml EX-101.PRE 10823
53 EXTRACTED XBRL INSTANCE DOCUMENT d915177d8k_htm.xml XML 3507
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37465 | Film No.: 25919235
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)